Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Lisinopril dihydrate
Essential Pharmaceuticals Limited
C09AA; C09AA03
Lisinopril dihydrate
1 milligram(s)/millilitre
Oral solution
ACE inhibitors, plain; lisinopril
Not marketed
2015-07-31
Lis1mgSoln-PL-IE-5 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT LISINOPRIL 1 MG/ML ORAL SOLUTION lisinopril READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. WHAT LISINOPRIL 1 MG/ML ORAL SOLUTION IS AND WHAT IT IS USED FOR 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE LISINOPRIL 1 MG/ML ORAL SOLUTION 3. HOW TO TAKE LISINOPRIL 1 MG/ML ORAL SOLUTION 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE LISINOPRIL 1 MG/ML ORAL SOLUTION 6. CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT LISINOPRIL 1 MG/ML ORAL SOLUTION IS AND WHAT IT IS USED FOR Lisinopril 1 mg/ml oral solution contains a medicine called lisinopril. This belongs to a group of medicines called ACE inhibitors. Lisinopril can be used for the following conditions: - to treat high blood pressure (hypertension) - to treat heart failure - if you have recently had a heart attack (myocardial infarction) - to treat kidney problems caused by Type II diabetes in people with high blood pressure. Lisinopril works by making your blood vessels widen. This helps to lower your blood pressure. It also makes it easier for your heart to pump blood to all parts of your body. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE LISINOPRIL 1 MG/ML ORAL SOLUTION DO NOT TAKE LISINOPRIL 1 MG/ML ORAL SOLUTION IF: - you are allergic (hypersensitive) to lisinopril or any of the other ingredients of Lisinopril 1 mg/ml oral solution (listed in Section 6) - you have ever had an allergic reaction to another ACE inhibitor medicine. The allergic reaction may have caused swelling of the hands, feet, an Read the complete document
Health Products Regulatory Authority 01 October 2020 CRN009W2M Page 1 of 14 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lisinopril 1mg/ml Oral Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of oral solution contains 1 mg lisinopril (as lisinopril dihydrate). Excipients with known effect Each ml contains 0.24 mg of sodium and 1.5 mg of benzoate salt For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral solution. The oral solution is clear and colourless with a sweet taste. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS _HYPERTENSION_ Treatment of hypertension. _HEART FAILURE_ Treatment of symptomatic heart failure. _ACUTE MYOCARDIAL INFARCTION_ Short-term (6 weeks) treatment of haemodynamically stable patients within 24 hours of an acute myocardial infarction. _RENAL COMPLICATIONS OF DIABETES MELLITUS_ Treatment of renal disease in hypertensive patients with Type 2 diabetes mellitus and incipient nephropathy (see section 5.1). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Lisinopril 1 mg/ml oral solution should be administered orally in a single daily dose. As with all other medication taken once daily, Lisinopril 1 mg/ml oral solution should be taken at approximately the same time each day. The absorption of Lisinopril 1 mg/ml oral solution is not affected by food. Mixing with food or drinks has not been studied, and any mixing with food and drinks is therefore the responsibility of the health care professional or the user. The dose should be individualised according to patient profile and blood pressure response (see section 4.4). _HYPERTENSION_ Lisinopril 1 mg/ml oral solution may be used as monotherapy or in combination with other classes of antihypertensive therapy (see sections 4.3, 4.4, 4.5 and 5.1). Starting dose In patients with hypertension the usual recommended starting dose is 10 mg. Patients with a strongly activated renin-angiotensin-aldosterone system (in particular, renovascular hypertension, salt and/or volume depletion, cardiac decompensatio Read the complete document